Elevance Health Inc (NYSE: ELV) has a price-to-earnings ratio of 16.81x that is above its average ratio. Additionally, the 36-month beta value for ELV is 0.83. There are mixed opinions on the stock, with 13 analysts rating it as a “buy,” 5 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The public float for ELV is 226.90M and currently, short sellers hold a 1.11% ratio of that float. The average trading volume of ELV on March 27, 2025 was 1.63M shares.
ELV) stock’s latest price update
Elevance Health Inc (NYSE: ELV)’s stock price has soared by 1.67 in relation to previous closing price of 423.47. Nevertheless, the company has seen a gain of 0.01% in its stock price over the last five trading days. zacks.com reported 2025-03-18 that With a strengthening commercial business, ELV is seeing steady membership growth.
ELV’s Market Performance
ELV’s stock has risen by 0.01% in the past week, with a monthly rise of 7.12% and a quarterly rise of 17.64%. The volatility ratio for the week is 2.30% while the volatility levels for the last 30 days are 2.52% for Elevance Health Inc The simple moving average for the last 20 days is 3.58% for ELV’s stock, with a simple moving average of -6.20% for the last 200 days.
Analysts’ Opinion of ELV
Many brokerage firms have already submitted their reports for ELV stocks, with Argus repeating the rating for ELV by listing it as a “Buy.” The predicted price for ELV in the upcoming period, according to Argus is $450 based on the research report published on March 17, 2025 of the current year 2025.
Stephens, on the other hand, stated in their research note that they expect to see ELV reach a price target of $440, previously predicting the price at $520. The rating they have provided for ELV stocks is “Equal-Weight” according to the report published on January 22nd, 2025.
ELV Trading at 6.95% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.10% of loss for the given period.
Volatility was left at 2.52%, however, over the last 30 days, the volatility rate increased by 2.30%, as shares surge +11.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.59% upper at present.
During the last 5 trading sessions, ELV rose by +0.01%, which changed the moving average for the period of 200-days by -20.43% in comparison to the 20-day moving average, which settled at $415.65. In addition, Elevance Health Inc saw 16.71% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Penczek Ronald W, who sale 443 shares at the price of $415.13 back on Mar 10 ’25. After this action, Penczek Ronald W now owns 1,847 shares of Elevance Health Inc, valued at $183,903 using the latest closing price.
Penczek Ronald W, the Officer of Elevance Health Inc, proposed sale 443 shares at $415.13 during a trade that took place back on Mar 10 ’25, which means that Penczek Ronald W is holding shares at $183,904 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.47 for the gross margin
The net margin for Elevance Health Inc stands at 0.03. The total capital return value is set at 0.09. Equity return is now at value 14.83, with 5.30 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 0.76. The interest coverage ratio of the stock is 6.7.
Currently, EBITDA for the company is 9.09 billion with net debt to EBITDA at 2.26. When we switch over and look at the enterprise to sales, we see a ratio of 0.68. The receivables turnover for the company is 9.27for trailing twelve months and the total asset turnover is 1.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.45.
Conclusion
In conclusion, Elevance Health Inc (ELV) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
